Clinical and epidemiological analysis of gastric and duodenal ulcer cases in Brazil between 2017 and 2024
DOI:
https://doi.org/10.33448/rsd-v14i5.48771Keywords:
Epidemiology; Gastric ulcer; Duodenal ulcer.Abstract
Introduction: Gastric and duodenal ulcers are prevalent conditions that affect the mucosa of the stomach and duodenum, respectively, and are associated with a significant impact on public health. Therefore, this article aims to provide a quantitative and temporal analysis of the epidemiological characteristics of gastric and duodenal ulcers from January 2017 to September 2024. Methodology: This is an epidemiological study carried out based on data from the health information department of the SUS (Unified Health System). The variables used were: hospital admissions, deaths, age group, color/race, sex, hospital expenses, and health macroregion.Methodology: This is an epidemiological study carried out based on data from the health information department of the SUS (Unified Health System). The variables used were: hospital admissions, deaths, age group, color/race, sex, hospital expenses and health macro-region. Results: 86,505 hospitalizations were due to ulcers and in the period analyzed the highest number of hospitalizations was in 2013. The Southeast region was the most reported regarding the number of hospitalizations and the one where most individuals died due to complications. The largest age group affected was between 60 and 69 years old. Males were the gender most affected by this pathology. Regarding ethnicity, more brown patients were hospitalized. In addition, the Southeast region had the highest average number of days of hospitalization. Conclusion: Understanding these trends is essential for formulating effective public health policies and for better allocation of resources for treating these diseases. In addition, epidemiological analysis can guide preventive actions, such as educational campaigns on the appropriate use of NSAIDs and the need to eradicate H. pylori.
References
Atay, A. et al. (2023). From dyspepsia to complicated peptic ulcer: New markers in diagnosis and prognosis. Eur Rev Med Pharmacol Sci. 27(4), 1352-9. doi: 10.26355/eurrev_202302_31370.
Bardhan, K. D. & Royston, C. (2008). Time, change and peptic ulcer disease in Rotherham, UK.Dig Liver Dis. 40(7), 540-6.
Bao, Y., Spiegelman, D., Li, R., Giovannucci, E., Fuchs, C. S. & Michaud, D. S. (2010). History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology. 138(2), 541-9.
Chiorean, M. V., Locke, G. R. 3rd, Zinsmeister, A. R., Schleck, C. D., Melton, L.J. 3rd. (2002). Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease. Am J Gastroenterol. 97(12), 3015-22.
Chisini, L. A. et al. (2021). Impact of the COVID-19 pandemic on prenatal, diabetes and medical appointments in the Brazilian National Health System. Revista Brasileira de Epidemiologia. 24, e210013.
Coelho, S. F. F., Pizetta, L. T., da Silveira, G. A., Frizon, G. J., Sampaio, A. L. S., de Souza, A. V., ... & de Almeida Melo, M. (2024). Úlcera gástrica e duodenal: uma análise atualizada do cenário da saúde digestiva no Brasil. Brazilian Journal of Implantology and Health Sciences. 6(8), 2264-74.
Denizar, J. G. M. et al. (2024). Doença ulcerosa péptica: epidemiologia, fisiopatologia, diagnóstico e tratamento. Revista Ibero-Americana de Humanidades, Ciências e Educação. 10(7), 3004–15.
Atay, A., Karahan, F., Gunes, O. & Gunay, S. (2023). From dyspepsia to complicated peptic ulcer: new markers in diagnosis and prognosis. European Review for Medical and Pharmacological Sciences, 27, 1352–9.
Graham, D. Y., Lidsky, M. D., Cox, A. M., Evans, D. J. Jr, Evans, D. G., Alpert, L., Klein, P. D., Sessoms, S. L., Michaletz, P. A. & Saeed, Z. A. (2020). Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 100(6), 1653-7.
Hawkey, C. J. et al. (2022). Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. The Lancet. 400, 10363, 1597–606.
Laucirica, I., Garcia Iglesias, P., & Calvet, X. (2023). Úlcera péptica. Medicina Clínica. 161(6), 260–66.
Lisboa, M. G. et al. (2024). Úlcera péptica - uma revisão de literature. Brazilian Journal of Health Review, Curitiba. 7(2), 1-12.
Loeb, D. S., Talley, N. J., Ahlquist, D. A., Carpenter, H. A. & Zinsmeister, A. R. (2020). Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 102(6), 1899-905.
Narayanan, M., Reddy, K. M. & Marsicano, E. (2018). Peptic Ulcer Disease and Helicobacter pylori infection. Missouri medicine. 115(3), 219-24. https://pubmed.ncbi.nlm.nih.gov/30228726/.
Pedraza, D. F., et al. (2017). Internações das crianças brasileiras menores de cinco anos: revisão sistemática da literatura. Epidemiologia e Serviços de Saúde, 26(1), 169–82.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Editora UAB/NTE/UFSM.
Shitsuka et al. (2014). Matemática fundamental para a tecnologia. Editora Érica.
Tham, K. T., Peek, R. M. Jr, Atherton, J. C., Cover, T. L., Perez-Perez, G. I., Shyr, Y. & Blaser, M. J. (2001). Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol. 32(3), 264-73.
Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área da Saúde. 2ed. Editora da UFRGS. Vieira, S. (2021). Introdução à bioestatística. Ed.GEN/Guanabara Koogan
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rainara Pereira dos Anjos; Lícia Ribeiro Mota; Ana Augusta Teles da Paixão; Sylvia Pereira Gurgel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
